Stock Comparison

KNSA vs AAPL

Side-by-side fundamentals, quality, value, and price momentum analysis.

Tickers 2 / 10100+ Metrics

Selected Stocks

Add up to 10 tickers. Use presets or search to get started.

2 / 10
Quick presets:

Metrics Comparison

Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.

MetricKNSAKiniksa Pharmaceuticals, Ltd.AAPLApple Inc.
Market Cap$1.71B$3.8T
Current Price$37.92$258.21
P/E Ratio-63.2034.61
Revenue Growth 1Y56.6%6.4%
Net Margin-10.2%26.9%
ROE-9.8%171.4%
ROIC-11.3%70.6%
Debt/Equity0.021.34
FCF Yield1.5%2.6%
Dividend Yield0.4%
Loading chart...

KNSA vs AAPL: Key Questions Answered

Which stock is growing the fastest: KNSA or AAPL?

Kiniksa Pharmaceuticals, Ltd. (KNSA) is growing the fastest with 56.6% revenue growth. Apple Inc. has the slowest growth at 6.4%. Higher growth often justifies higher valuations.

Which has the best profit margins: KNSA or AAPL?

Apple Inc. (AAPL) has the strongest profitability with a 26.9% net margin. Kiniksa Pharmaceuticals, Ltd. has the lowest at -10.2%. Higher margins indicate pricing power and efficiency.

Which is the largest company: KNSA or AAPL?

Apple Inc. (AAPL) is the largest company with a market cap of $3.80T. Kiniksa Pharmaceuticals, Ltd. is the smallest at $1.7B. Larger companies tend to be more stable but may have less growth potential.

Which stock has the best return on equity: KNSA or AAPL?

Apple Inc. (AAPL) generates the best returns on shareholder equity with an ROE of 1.7%. Kiniksa Pharmaceuticals, Ltd. has the lowest at -9.8%. Higher ROE indicates efficient use of capital.